Stockscreener 앱 받기
2.04
3.32%
-0.07
시간 외 거래:
2.08
0.04
+1.96%
전일 마감가:
$2.11
열려 있는:
$2.15
하루 거래량:
102.37K
Relative Volume:
0.90
시가총액:
$38.09M
수익:
순이익/손실:
주가수익비율:
-
EPS:
-
순현금흐름:
1주 성능:
-22.73%
1개월 성능:
-49.13%
6개월 성능:
-56.41%
1년 성능:
-57.75%
1일 변동 폭
$1.8801
$2.30
1주일 범위
$1.8801
$2.6999
52주 변동 폭
$1.8801
$8.40
BioStem Technologies, Inc. Common Stock Stock (BSEM) Company Profile
Compare BSEM vs VRTX, MRNA, REGN, ARGX, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BSEM
BioStem Technologies, Inc. Common Stock
|
2.04 | 38.09M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
508.75 | 128.95B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
236.50 | 94.42B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
796.34 | 81.99B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
846.27 | 53.22B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
374.08 | 42.32B | 5.76B | 514.49M | 1.10B | 4.4813 |
BioStem Technologies, Inc. Common Stock 주식(BSEM)의 최신 뉴스
BioStem Technologies Completes $3 Million Private Placement Financing - The Globe and Mail
BioStem Technologies Completes $3 Million Private Stock and Warrants Offering - Kalkine Media
BioStem Technologies Secures $3 Million Private Placement; Issues Stock at $4.08 and Warrants - TradingView
BioStem Technologies raises $3M in private placement By Investing.com - Investing.com South Africa
BioStem Technologies raises $3M in private placement - Investing.com
BioStem Technologies Announces $3 Million Private Placement Priced At-The-Market Under Nasdaq Rules - GlobeNewswire
BioStem (BSEM) lines up $40M in potential stock sales—how much has it tapped? - Stock Titan
BioStem Technologies Establishes $40 Million Committed Equity Facility With Roth Principal Investments - TradingView
New stock sale deal could fund BioStem (NASDAQ: BSEM) for up to three years - Stock Titan
BioStem Technologies Secures Access to $40 Million Equity Facility - citybiz
BioStem Technologies Secures Up to $40 Million in a Committed Equity Facility - GlobeNewswire
BioStem (NASDAQ: BSEM) lines up $40M stock deal that could dilute investors - Stock Titan
Up to $40 million in shares could be sold by BioStem. It does not have to use the facility. - Stock Titan
BioStem Technologies (BSEM) CAO increases direct holdings with RSU share conversion - Stock Titan
BioStem Technologies (BSEM) director now holds 33,928 shares after RSU exercise - Stock Titan
BioStem Technologies (BSEM) CEO receives 25K shares via RSUs - Stock Titan
BioStem Technologies (BSEM) CFO lifts direct stake to 58,062 shares - Stock Titan
BioStem Technologies (BSEM) insider adds 17,196 shares at $0 - Stock Titan
BioStem Technologies (BSEM) CCO adds 500 shares through equity award - Stock Titan
BioStem Technologies (BSEM) director gains 7,671 shares - Stock Titan
BioStem Technologies Reports Second Quarter 2026 Financial Results - GlobeNewswire
BioStem Technologies wins Nasdaq approval, begins trading August 7 - Dealroom
BioStem Technologies (Nasdaq:BSEM)Stock Analysis - Simply Wall Street
BioStem Technologies, Inc. (BSEM) Company Information - Simply Wall Street
BioStem Technologies Uplists to Nasdaq Capital Market - The Globe and Mail
symbol__ Stock Quote Price and Forecast - CNN
BioStem Technologies Uplists to Nasdaq Capital Market - TipRanks
BioStem Technologies Announces Nasdaq Uplisting - GlobeNewswire
BioStem Technologies Publicly Files Form 10 Registration Statement with the Securities and Exchange Commission - Yahoo Finance
BioStem Technologies, Inc. Common Stock (BSEM) 재무 분석
BioStem Technologies, Inc. Common Stock (BSEM)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
BioStem Technologies, Inc. Common Stock 주식 (BSEM) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Matuszewski Jason | Chief Executive Officer |
Oct 07 '26 |
Option Exercise |
2.00 |
250,000 |
500,000 |
1,553,551 |
| SMITH-VAN VURST ANDREW | Chief Operating Officer |
Sep 17 '26 |
Option Exercise |
0.00 |
9,574 |
0 |
1,539,809 |
| Matuszewski Jason | Chief Executive Officer |
Sep 17 '26 |
Option Exercise |
0.00 |
16,650 |
0 |
1,303,552 |
| SMITH-VAN VURST ANDREW | Chief Operating Officer |
Sep 15 '26 |
Option Exercise |
0.00 |
7,622 |
0 |
1,530,235 |
| POE BRANDON | Chief Financial Officer |
Sep 15 '26 |
Option Exercise |
0.00 |
1,694 |
0 |
58,062 |
| Matuszewski Jason | Chief Executive Officer |
Sep 15 '26 |
Option Exercise |
0.00 |
8,469 |
0 |
1,286,902 |
| WARRINGTON KENNETH HOWARD JR | Director |
Sep 15 '26 |
Option Exercise |
0.00 |
1,694 |
0 |
33,928 |
| FORTUNATO MICHAEL A | Chief Accounting Officer |
Sep 15 '26 |
Option Exercise |
0.00 |
4,234 |
0 |
68,664 |
| HASSETT BARRY | Chief Commercial Officer |
Sep 09 '26 |
Option Exercise |
0.00 |
500 |
0 |
5,003 |
| UNGRODT JODI | Director |
Aug 27 '26 |
Option Exercise |
0.00 |
5,647 |
0 |
11,295 |
1.35%
자본화:
|
볼륨(24시간):